Azenta, Inc.

Azenta, Inc.

AZTAยทNASDAQ

$23.89

+2.0%
HealthcareMedical - Instruments & Supplies

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

At a Glance

Live Snapshot
Market Cap$1.10B
EPS-1.2200
P/E Ratio-19.58
Earnings Date08/04/2026
Azenta, Inc.

Azenta, Inc. Fair Value Envelope

AZTA ยท NASDAQ

Our analysis suggests that AZTA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $23.89, this represents a potential HIDDEN relative to our calculated worth for Azenta, Inc..

Intrinsic Value
Current Price: $23.89

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$594.7B
+ Cash & Equivalents$279.8M
Firm Value$595.0B
- Debt$111.2M
Equity Value$594.9B
/ Shares Outstanding45,839,728B
DCF Value$13.0K
UNDERVALUED BY 54222%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$144.4M
$288.7M
$577.4M
$1.2B
$2.3B
$4.6B
$9.2B
$18.5B
$37.0B
$73.9B
Maintenance CapEx
-$13.5M
-$27.1M
-$54.2M
-$108.3M
-$216.7M
-$433.4M
-$866.7M
-$1.7B
-$3.5B
-$6.9B
Owner Earnings
$130.8M
$261.6M
$523.3M
$1.0B
$2.1B
$4.2B
$8.4B
$16.7B
$33.5B
$67.0B
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$121.1M
$224.3M
$415.4M
$769.2M
$1.4B
$2.6B
$4.9B
$9.0B
$16.8B
$31.0B
Terminal Value represents 88.7% of Enterprise Value